Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy.

Infect Agent Cancer · 2022 · PMC9727898 · PMID 36476371

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Dynamic changes of HBV serological markers and biochemical indicators during 48 weeks of NA treatment therapy The total HBV serological markers and biochemical indicators presented a decreasing trend from baseline to 48 weeks.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.